LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 114 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.30 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,093,000 | -63.5% | 376,502 | -56.4% | 0.34% | -65.1% |
| Q4 2018 | $5,728,000 | -37.8% | 862,602 | 0.0% | 0.96% | -33.3% |
| Q3 2018 | $9,204,000 | -11.1% | 862,602 | 0.0% | 1.44% | -16.1% |
| Q2 2018 | $10,351,000 | +41.3% | 862,602 | +0.9% | 1.72% | +30.3% |
| Q1 2018 | $7,324,000 | -11.4% | 854,592 | +2.1% | 1.32% | -5.0% |
| Q4 2017 | $8,271,000 | -8.7% | 837,192 | +13.5% | 1.39% | +0.7% |
| Q3 2017 | $9,063,000 | -11.5% | 737,453 | +18.4% | 1.38% | -7.3% |
| Q2 2017 | $10,243,000 | +115.0% | 622,655 | +87.4% | 1.49% | +96.4% |
| Q1 2017 | $4,765,000 | – | 332,300 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |